Vimarsana
Biggest News Aggregation in the World

Page 42 - Cosmetics Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cosmetics Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cosmetics Act Today - Breaking & Trending Today

dcgi: DCGI asks states to keep vigil on sale of falsified versions of 2 drugs following WHO alerts - Vimarsana News

dcgi: DCGI asks states to keep vigil on sale of falsified versions of 2 drugs following WHO alerts

The Drugs Controller General of India (DCGI) has issued an advisory to keep a strict watch on the sale and distribution of falsified versions of two drugs, Defitelio and Adcetris, following alerts from the World Health Organisation (WHO). The WHO has identified multiple falsified versions of Adcetris in circulation, and a falsified version of Defitelio has also been detected.

DCGI asks states to keep vigil on sale of falsified versions of 2 drugs following WHO alerts - Vimarsana News

DCGI asks states to keep vigil on sale of falsified versions of 2 drugs following WHO alerts

In an advisory on September 5, the DCGI said the WHO has issued a safety alert identified with multiple falsified versions of Adcetris injection 50 mg manufactured by Takeda Pharmaceutical Company Limited, identified in four different countries including India.

Formal communicaFollowing WHO alerts, DCGI asks states to keep vigil on sale of falsified versions of 2 drugs - Vimarsana News

Formal communicaFollowing WHO alerts, DCGI asks states to keep vigil on sale of falsified versions of 2 drugs

Agencies New Delhi, Sept 10: The Drugs Controller General of India (DCGI) has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified versions of two drugs, liver medication Defitelio and Takeda’s cancer drug Adcetris (injection), following alerts issued by the World Health

digene: Digene users, take note! Health regulator has issued an important advisory for you - Vimarsana News

digene: Digene users, take note! Health regulator has issued an important advisory for you

The Drug Controller General of India has issued a cautionary advisory to doctors and healthcare professionals regarding the discontinuation of Digene gel in the event of adverse drug reactions. This follows a complaint received by the DCGI about a batch of Digene gel produced by Abbott India in Goa, which had unusual characteristics.

DCGI issues alert against Abbott's antacid Digene gel after company initiates voluntary recall - Vimarsana News

DCGI issues alert against Abbott's antacid Digene gel after company initiates voluntary recall

The regulator has asked patients to discontinue the use of Digene Gel products, which were manufactured at the Goa Facility